• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cerulean Pharma Inc

+ Add to Watchlist

CERU:US

6.0100 USD 0.2000 3.22%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Cerulean Pharma Inc (CERU)

Open: 6.1800 Day's Range: 5.8100 - 6.1800 Volume: 39,068
Previous Close: 6.2100 52wk Range: 3.3500 - 8.0600 1-Yr Rtn: -

Stock Chart for CERU

No chart data available.
  • CERU:US 6.0100
  • 1D
  • 1M
  • 1Y
6.2100
Interactive CERU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CERU

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.8030
Est. PEG Ratio -
Market Cap (M USD) 120.95
Shares Outstanding (M) 20.13
30 Day Average Volume 19,866
Price/Book (mrq) 2.3024
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CERU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CERU

Cerulean Pharma, Inc. designs and develops pharmaceutical products. The Company manufactures therapeutics in the areas of oncology, cardiovascular, autoimmune, and inflammatory diseases as well as tumor cells. Cerulean Pharma operates in the United States.

Paul A FriedmanChairmanChristopher Damien T Guiffre "Chris"Chief Operating Officer
Edward GarmeySenior VP/Chief Medical OfcrKaren RobertsSenior VP:Finance & Admin
More Company Profile & Key Executives for CERU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil